PD-L2, commonly expressed on tumor cells, macrophages, and dendritic cells (10), is another ligand of the PD-1 receptor, and has approximately 2-6-fold higher affinity compared to PD-L1 (11). This evidence concerns the gene PDCD1LG2 and neoplasm.